Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News & Views
  • Published:

Management of drug toxicity in patients with renal insufficiency

Medication errors frequently occur in the treatment of patients with renal insufficiency and can cause serious adverse events. Although computerized systems that adjust the drug dose on the basis of a patient's glomerular filtration rate can reduce the incidence and severity of drug prescription errors, other variables can also affect the susceptibility of patients with renal dysfunction to drug toxicity.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

References

  1. Hug, B. L. et al. Occurrence of adverse, often preventable, events in community hospitals involving nephrotoxic drugs or those excreted by the kidney. Kidney Int. 76, 1192–1198 (2009).

    Article  Google Scholar 

  2. Chertow, G. M. et al. Guided medication dosing for inpatients with renal insufficiency. JAMA 286, 2839–2844 (2001).

    Article  CAS  Google Scholar 

  3. Colpaert, K. et al. Impact of computerized physician order entry on medication prescription errors in the intensive care unit: a controlled cross-sectional trial. Crit. Care 10, R21 (2006).

    Article  Google Scholar 

  4. Fink, J. C. & Chertow, G. M. Medication errors in chronic kidney disease: one piece in the patient safety puzzle. Kidney Int. 76, 1123–1125 (2009).

    Article  Google Scholar 

  5. Verbeeck, R. K. & Musuamba, F. T. Pharmacokinetics and dosage adjustment in patients with renal dysfunction. Eur. J. Clin. Pharmacol. 65, 757–773 (2009).

    Article  CAS  Google Scholar 

  6. Gabardi, S. & Abramson, S. Drug dosing in chronic kidney disease. Med. Clin. North Am. 89, 649–687 (2005).

    Article  CAS  Google Scholar 

  7. Tavares-Almeida, I., Gulyassy, P. F., Depner, T. A. & Jarrard, E. A. Aromatic amino acid metabolites as potential protein binding inhibitors in human uremic plasma. Biochem. Pharmacol. 34, 2431–2438 (1985).

    Article  CAS  Google Scholar 

  8. Pedone, C. et al. Reliability of equations to estimate glomerular filtration rate in the very old. Aging Clin. Exp. Res. 20, 496–502 (2008).

    Article  Google Scholar 

  9. Pratt, N., Roughead, E. E., Ryan, P. & Gilbert, A. L. Differential impact of NSAIDs on rate of adverse events that require hospitalization in high-risk and general veteran populations: a retrospective cohort study. Drugs Aging 27, 63–71 (2010).

    Article  CAS  Google Scholar 

  10. Karras, A., Martinez, F. & Droz, D. in Oxford Text of Clinical Nephrology. Acute tubulointerstitial nephritis (eds Davison, A. M. et al.) 1531–1544 (Oxford University Press, Oxford, UK, 2005).

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Giorgio Graziani.

Ethics declarations

Competing interests

C. Ponticelli declares an association with the following company: Novartis, as consultant. G. Graziani declares no competing interests.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ponticelli, C., Graziani, G. Management of drug toxicity in patients with renal insufficiency. Nat Rev Nephrol 6, 317–318 (2010). https://doi.org/10.1038/nrneph.2010.43

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1038/nrneph.2010.43

Search

Quick links

Nature Briefing: Translational Research

Sign up for the Nature Briefing: Translational Research newsletter — top stories in biotechnology, drug discovery and pharma.

Get what matters in translational research, free to your inbox weekly. Sign up for Nature Briefing: Translational Research